These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32780750)

  • 1. Simultaneous separation of naproxen and 6-O-desmethylnaproxen metabolite in saliva samples by liquid chromatography-tandem mass spectrometry: Pharmacokinetic study of naproxen alone and associated with esomeprazole.
    Dionísio TJ; Oliveira GM; Morettin M; Faria FC; Santos CF; Calvo AM
    PLoS One; 2020; 15(8):e0236297. PubMed ID: 32780750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous separation of naproxen and 6-O-desmethylnaproxen metabolite in saliva samples by liquid chromatography-tandem mass spectrometry: Pharmacokinetic study of naproxen alone and associated with esomeprazol-Results.
    Oliveira GM; Dionísio TJ; Polanco NLDH; Siqueira-Sandrin VS; Faria FAC; Santos CF; Calvo AM
    PLoS One; 2022; 17(12):e0278411. PubMed ID: 36454922
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Oliveira GM; Dionísio TJ; Siqueira-Sandrin VS; Ferrari LAL; Bolani B; Parisi VA; Polanco NLDH; Colombini-Ishikiriama BL; Faria FAC; Santos CF; Calvo AM
    Metabolites; 2022 Nov; 12(11):. PubMed ID: 36422246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic comparison study of a combination containing 500 mg of Naproxen and 20 mg of Esomeprazole: a randomized, single-dose, 2-way crossover, open-label study in healthy Korean men.
    Choi HG; Jeon JY; Kwak SS; Kim H; Jin C; Im YJ; Kim EY; Wang HM; Kim Y; Lee SY; Kim MG
    Clin Ther; 2015 Jan; 37(1):83-93. PubMed ID: 25482305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers.
    Choi Y; Han H; Shin D; Lim KS; Yu KS
    Drug Des Devel Ther; 2015; 9():4127-35. PubMed ID: 26257511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and relative bioavailability of a fixed-dose combination of enteric-coated naproxen and non-enteric-coated esomeprazole magnesium.
    Wang-Smith L; Fort J; Zhang Y; Sostek M
    J Clin Pharmacol; 2012 May; 52(5):670-80. PubMed ID: 21628602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of naproxen and esomeprazole in beagle dog plasma by supercritical fluid chromatography-tandem mass spectrometry coupled with evaporation-free liquid-liquid extraction.
    Yang Y; Li X; Zhou Q; Sun L; Zhang T
    J Pharm Biomed Anal; 2021 Jan; 193():113668. PubMed ID: 33176242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis.
    Lovell DJ; Dare JA; Francis-Sedlak M; Ball J; LaMoreaux BD; Von Scheven E; Reinhardt A; Jerath R; Alpan O; Gupta R; Goldsmith D; Zeft A; Naddaf H; Gottlieb B; Jung L; Holt RJ
    Pediatr Rheumatol Online J; 2018 Jun; 16(1):41. PubMed ID: 29941047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a sensitive and high-throughput LC-MS/MS method for the simultaneous determination of esomeprazole and naproxen in human plasma.
    Gopinath S; Kumar RS; Shankar MB; Danabal P
    Biomed Chromatogr; 2013 Jul; 27(7):894-9. PubMed ID: 23483550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro dissolution and in vivo bioavailability of diflunisal/naproxen fixed-dose combination tablets and concomitant administration of diflunisal and naproxen in healthy adult subjects.
    Helmy SA; El Bedaiwy HM
    Drug Res (Stuttg); 2013 Mar; 63(3):150-8. PubMed ID: 23444169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous quantitative determination of naproxen, its metabolite 6-O-desmethylnaproxen and their five conjugates in plasma and urine samples by high-performance liquid chromatography on dynamically modified silica.
    Andersen JV; Hansen SH
    J Chromatogr; 1992 Jun; 577(2):325-33. PubMed ID: 1400763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High performance liquid chromatography with photo diode array for separation and analysis of naproxen and esomeprazole in presence of their chiral impurities: Enantiomeric purity determination in tablets.
    Ragab MAA; El-Kimary EI
    J Chromatogr A; 2017 May; 1497():110-117. PubMed ID: 28366568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of naproxen and its metabolite O-desmethylnaproxen with their acyl glucuronides in human plasma and urine by means of direct gradient high-performance liquid chromatography.
    Vree TB; van den Biggelaar-Martea M; Verwey-van Wissen CP
    J Chromatogr; 1992 Jul; 578(2):239-49. PubMed ID: 1400803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous quantification of naproxcinod and its active metabolite naproxen in rat plasma using LC-MS/MS: application to a pharmacokinetic study.
    Shi X; Shang W; Wang S; Xue N; Hao Y; Wang Y; Sun M; Du Y; Cao D; Zhang K; Shi Q
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 978-979():157-62. PubMed ID: 25550191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of an LC-ESI-MS/MS method for the simultaneous quantification of naproxen and sumatriptan in human plasma: application to a pharmacokinetic study.
    Brêtas JM; César IC; Brêtas CM; Teixeira Lde S; Bellorio KB; Mundim IM; Pianetti GA
    Anal Bioanal Chem; 2016 Jun; 408(15):3981-92. PubMed ID: 27020929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchronized determination of sacubitril and valsartan with some co-administered drugs in human plasma via UPLC-MS/MS method using solid-phase extraction.
    Moussa BA; Hashem HMA; Mahrouse MA; Mahmoud ST
    Biomed Chromatogr; 2021 Nov; 35(11):e5203. PubMed ID: 34145610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine.
    Haberer LJ; Walls CM; Lener SE; Taylor DR; McDonald SA
    Headache; 2010 Mar; 50(3):357-73. PubMed ID: 20132340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Separation and determination of naproxen by reversed-phase high performance liquid chromatography].
    Wang C; Zou G
    Se Pu; 1998 May; 16(3):255-7. PubMed ID: 11327005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of a fixed-dose combination of nimesulide/pantoprazole compared to naproxen/esomeprazole for pain relief in patients with osteoarticular diseases and dyspeptic symptoms.
    Scheinberg M; Pott Júnior H; Macêdo EA; Bocchi de Oliveira MF; Ecclissato C; Amazonas RB
    Drug Des Devel Ther; 2018; 12():2775-2783. PubMed ID: 30233140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.